In vitro synthesis of interferon-γ, interleukin-4, transforming growth factor-β and interleukin-1β by peripheral blood mononuclear cells from tuberculosis patients: Relationship with the severity of pulmonary involvement

Scandinavian Journal of Immunology

Volumn 49, Issue 2, 1999, Pages 210-217

  Dlugovitzky, D ^b   Bay, M L ^b   Rateni, L ^b   Urizar L ^b   Rondelli, C F M ^b   Largacha, C ^b   Farroni, M A ^b   Molteni, O ^b   Bottasso, Oscar A ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG TUBERCULOSIS; LYMPHOCYTE PROLIFERATION; MALE; MONONUCLEAR CELL; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTIGENS, BACTERIAL; CELLS, CULTURED; CONCANAVALIN A; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; LUNG DISEASES; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA; TUBERCULOSIS;

EID: 0033045726     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1999.00492.x     Document Type: Article

References (46)

1. Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Org 1994;72:213-20.
2. Farebee SH. Controlled chemoprophylaxis trials in tuberculosis. A review. Rev Adv Tuberc Res 1970;17:29-106.
3. Harboe M, Andersen P, Colston MJ et al. Vaccines against tuberculosis. Vaccine 1996;14:701-16.
4. Boom WH. The role of T-cell subsets in Mycobacterium tuberculosis infection. Infect Agents Dis 1996;5:73-81.
5. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-73.
6. Scott P, Kaufmann SHE. The role of T-cell subsets and cytokines in the regulation of infection. Immunol Today 1991;12:346-8.
7. Lucey DR, Clerici M, Shearer GM. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory disease. Clin Microbiol Rev 1996;9:532-62.
8. Sieling PA, Abrams JS, Yamamura M et al. Immunosuppressive roles for IL-10 and IL-4 in human infection: in vitro modulation of T cell responses in leprosy. J Immunol 1993;150:5501-10.
9. Dlugovitzky D, Torres-Morales A, Rateni L et al. Circulating profile of Th1 and Th2 cytokines in tuberculosis patients with different degrees of pulmonary involvement. FEMS Immunol Microbiol 1997;18:203-7.
10. Orme I. Immunity to mycobacteria. Curr Opin Immunol 1993;5:497-502.
11. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russel DG, Orme IM. Disseminated tuberculosis in IFN-γ gene-disrupted mice. J Exp Med 1993;178:2243-9.
12. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon-γ resistance to Mycobacterium tuberculosis. J Exp Med 1993;178:2249-52.
13. Rook GAW, Steele J, Fraher L et al. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 1986;57:159-63.
14. Denis M, Gregg EO, Ghandirian E. Cytokine modulation of Mycobacterium tuberculosis growth in human macrophages. Int J Immunopharmacol 1990;12:721-7.
15. Condos R, Rom WN, Schluger NW. Treatment of multidrug-resistant pulmonary tuberculosis with interferon-γ, via aerosol. Lancet 1997;349:1513-5.
16. Romagnani S. Lymphokine production by human T-cells in disease states. Annu Rev Immunol 1994;12:227-57.
17. Oppenheim JJ, Stradler BM, Siraganian RP, Mage M, Mathieson B. Lymphokines: their role in lymphocyte response. Properties of interleukin-1. Fed Proc 1982;41:257-62.
18. Tartakovsky BA, Finnegan A, Muegge K et al. IL-1 is an autocrine growth factor for T-cell lines. J Immunol 1988;141:3863-7.
19. Denis M, Ghadirian E. Interleukin-1 is involved in mouse resistance to Mycobacterium avium. Infect Immun 1994;62:457-61.
20. Ho JL, Badaró R, Schwartz A et al. Diminished in vitro production of interleukin-1 and tumor necrosis factor-α during acute visceral leishmaniasis and recovery after therapy. J Infect Dis 1992;165:1094-102.
21. Mitsuyama M, Igarashi KI, Kawamura I, Ohmori T, Nomoto K. Difference in the induction of macrophage interleukin-1 production between viable and killed cellls of Listeria monocytogenes. Infect Immun 1990;58:1254-60.
22. Fujiwara H, Kleinhenz ME, Wallis RS, Ellner JJ. Increased interleukin-1 production and monocyte suppressor cell activity associated with human tuberculosis. Am Rev Respir Dis 1986;133:73-7.
23. Chensue SW, Warmington KS, Berger AE, Tracey DE. Immunohistochemical demonstration of interleukin-1 receptor antagonist protein and interleukin-1 in human lymphoid tissue and granulomas. Am J Pathol 1992;140:269-75.
24. Juffermans NP, Verbon A, van Deventer SJH, van Deutekom H, Speelman P, van der Poll T. Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis. Am J Respir Crit Care Med 1998;157:1328-31.
25. Scollard DM. Inside the skin: the local immune and inflammatory milieu leprosy. Am J Trop Med Hyg 1991;44 (Suppl.):17-23.
26. Sieling PA, Modlin RL. T cell and cytokine patterns in leprosy skin lesions. Springer Semin Immunopathol 1992;13:413-26.
27. Bergeron A, Bonay M, Kambouchner M et al. Cytokine patterns in tuberculous and sarcoid granulomas. J Immunol 1997;159:3034-43.
28. O'Garra A, Murphy K. Role of cytokines in determining T lymphocyte function. Curr Opin Immunol 1994;6:458-66.
29. Tsunawaki S, Sporn M, Ding A, Nathan C. Deactivation of macrophages by transforming growth factor-β. Nature 1988;334:260-2.
30. Hirsch CS, Yoneda T, Averill L, Ellner JJ, Toosi Z. Enhancement of intracellular growth of Mycobacterium tuberculosis in human monocytes by transforming growth factor-β1. J Infect Dis 1994;170:1229-37.
31. Espevik T, Figari IS, Shalaby MR et al. Inhibition of cytokine production by cyclosporin A and transforming growth factor β. J Exp Med 1987;166:571-6.
32. Durham DM, Arkins S, Edward CK, Dantzer R-III, Kelley KW. Role of interferon-γ in counteracting the suppressive effects of transforming growth factor-β2 and glucocorticoids on the production of tumor necrosis factor-α. J Leukocyte Biol 1990;48:473-81.
33. Swain SL, Huston G, Tonkonogy S, Weinberg A. Transforming growth factor β and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J Immunol 1991;147:2991-3000.
34. Takeuchi M, Kosiewicz MM, Alard P, Streilein JW. On the mechanism by which transforming growth factor-β2 alters antigen-presenting abilities of macrophages on T cell activation. Eur J Immunol 1997;27:1648-56.
35. Tada T, Ohzeki S, Utsumi K et al. Transforming growth factor-β-induced inhibition of T cell function. J Immunol 1991;146:1077-82.
36. Toosi Z, Gogate P, Shiratsuchi H, Young T, Ellner JJ. Enhanced production of TGF-β by blood monocytes from patients with active tuberculosis and presence of TGF-β in tuberculous granulomatous lung lesions. J Immunol 1995;154:465-73.
37. Hirsh CS, Hussain R, Toosi Z, Dawood G, Shadid F, Ellner JJ. Cross modulation by transforming growth factor β in human tuberculosis: suppression of antigen-driven blastogenesis and interferon γ production. Proc Nail Acad Sci USA 1996;93:3193-8.
38. Bretscher PA. The regulatory function of CD4+ and CD8+ T cell subsets in immune class regulation. Res Immunol 1991;142:45-50.
39. Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H. Establishment of stable, cell-mediated immunity that makes 'susceptible' mice resistant to Leishmania major. Science 1992;257:539-42.
40. Gajewski TF, Fitch FW. Anti-proliferative effect of IFN-γ in immune regulation. I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine HTL clones. J Immunol 1988;140:4245-52.
41. Maggi E, Parronchi P, Manetti R et al. Reciprocal regulatory effects of IFN-γ and IL-4 on the in vitro development of human Th1 and Th2 clones. J Immunol 1992;148:2142-7.
42. Bogdan C, Paik J, Vodovotz Y, Nathan C. Contrasting mechanism for suppression of macrophage cytokine release by transforming growth factor-β and interleukin- 10. J Biol Chem 1992;267:23301-8.
43. Sánchez FO, Rodríguez JI, Agudelo G, García LF. Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls. Infect Immun 1994;62:5673-8.
44. Zhang M, Lin YG, Iyer DV, Gong JH, Abrams JS, Barnes PF. T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun 1995;63:3231-4.
45. Surcel HM, Troye-Blomberg M, Paulie S et al. Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 1994;81:171-6.
46. Sodhi A, Gong JH, Silva C, Qian D, Baes PF. Clinical correlates of interferon γ production in patients with tuberculosis. Clin Infect Dis 1997;25: 617-20.